Brazil health regulator Anvisa allows Chinese COVID-19 vaccine trial

Saturday, 4 July 2020 16:32

Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.

Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.

According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.

It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.

More from International News

Race to reach trapped survivors offers hope in Colombia quake zone

Rescuers raced in Colombia on Friday to free four people from a collapsed hotel, a rare sign of hope nearly four days after one of the strongest earthquakes to hit the Andean nation in decades left hundreds dead or missing.
France's top court blocks social media ban for under-15s

France's top court on Friday blocked a bill banning social media access for under-15s, saying it infringed upon freedom of expression and delivering a setback for President Emmanuel Macron, who asked his government to rewrite the legislation.
Japan's record rains strand thousands at Narita airport; kill eight

Record rainfall in Japan stranded thousands of travellers at Tokyo's Narita airport on Friday, bringing floods to the surrounding area that disrupted transport, knocked out power to 20,000 homes and killed eight.
Wildfires in Britain hit record levels after homes burn in intense heat

Wildfires in England and Wales have hit a record level, fire chiefs said on Friday, warning that rescue services were battling to keep up with rising risks a day after fires raced from tinder-dry fields to engulf houses on the hottest day of the year.